|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|
| ASSETS | |||||
| Current assets | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Total current assets | |||||
| Other noncurrent assets | |||||
| Investments held in Trust Account | |||||
| TOTAL ASSETS | |||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | |||||
| Current liabilities | |||||
| Accounts payable and accrued expenses | |||||
| Accrued offering costs | |||||
| Promissory note – related party | |||||
| Total current liabilities | |||||
| Deferred underwriting fee payable | |||||
| Warrant liabilities | |||||
| TOTAL LIABILITIES | |||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 500,000,000 shares authorized; 23,000,000 shares at redemption value as of September 30, 2022 and December 31, 2021 | |||||
| Class A ordinary shares | |||||
| Total class A ordinary shares subject to possible redemption, $0.0001 par value; 500,000,000 shares authorized; 23,000,000 shares at redemption value as of September 30, 2022 and December 31, 2021 | |||||
| Shareholders’ Deficit | |||||
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized, no shares issued and outstanding (excluding 23,000,000 shares subject to possible redemption) as of September 30, 2022 and December 31, 2021 | |||||
| Class B ordinary shares, each having a par or nominal value of approximately $0.00009; 53,333,345.5 shares authorized; 7,666,667 shares issued and outstanding as of September 30, 2022 and December 31, 2021 | |||||
| Accumulated deficit | |||||
| Shareholders’ Deficit | |||||
| Class B ordinary shares | |||||
| Total Shareholders’ Deficit | |||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT |
Loading...
